Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report

被引:8
|
作者
Wang, Ping [1 ]
Wang, Zhaoming
Kong, Yunyi
Xu, Aie
机构
[1] Anhui Med Univ, Affiliated Hosp Hangzhou 3, Dept Dermatol, Hangzhou 310009, Zhejiang, Peoples R China
关键词
EUROPEAN ORGANIZATION; MARKER BDCA-2; CLASSIFICATION; EXPRESSION; ENTITY; TUMOR; SKIN;
D O I
10.1111/j.1365-4632.2009.03777.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A previously healthy 44-year-old Chinese man presented with a nonitching, painless, skin lesion on the right lateral abdomen of 1-year duration. This lesion presented initially as a nodule of approximately 0.5 cm in diameter, which eventually grew to the size of an egg by August 2006. The patient had experienced no systemic symptoms, and his past medical and family history were noncontributory. Physical examination was normal except for the skin lesion. Peripheral lymph nodes were not palpable. Skin examination showed a lobulated, contusiform, brownish, infiltrated nodule with a wide base on the right lateral abdomen (Fig. 1). Histologic examination of a biopsy specimen taken from the lesion revealed the presence of a dense dermal lymphomatous infiltrate with a diffuse growth pattern, which extended into the subcutis. The Grenz zone was present. No signs of necrosis, karyorrhexis, hemophagocytosis, or angiocentric infiltrate were found (Fig. 2a). The tumor was composed of medium-sized pleomorphic cells with dispersed chromatin and absent or indistinct nucleoli, resembling lymphoblasts. Frequent mitosis was seen (Fig. 2b). Immunohistochemical studies revealed the reactivity of more than 90% of the cells with CD56, CD4, and CD43 (Fig. 3a, b). Immunostaining for CD3, CD8, CD20, CD30, CD68, CD79a, CD99, T-cell intracellular antigen-1 (TIA-1), Gallyas-Braak silver (GB), L26, Kp-1, myeloperoxidase (MPO), and terminal deoxynucleotidyl transferase (TdT) was either weak or negative. Clonal rearrangement of the T-cell receptor (TCR) was not detected by polymerase chain reaction (PCR). Epstein-Barr virus (EBV) staining of the skin biopsy specimen was negative. Laboratory examinations, including complete blood examination with peripheral blood smear, liver enzymes, electrolyte levels, kidney function, antinuclear antibody, and urine analysis, were all normal. EBV antibodies were negative. Chest radiograph, nasal bone X-ray, and bone marrow biopsy revealed no abnormal findings. Computed tomography of the nasal cavity, abdomen, and pelvis was normal. On the basis of the aforementioned clinical, histopathologic, and immunohistochemical findings, the patient was diagnosed with primary cutaneous CD4(+)/CD56(+) hematodermic neoplasm [ blastic natural killer (NK)-cell lymphoma]. After receiving a diagnosis of a very aggressive malignancy, the patient refused chemotherapy until right groin lymphadenopathy occurred 6 months later. In February 2007, the lesion was excised and showed the same pathologic features, consistent with cutaneous blastic NK-cell lymphoma. From March 2007, the patient received five courses of polychemotherapy with cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP). The lymphadenopathy disappeared after one cycle of chemotherapy. The patient received four more cycles of chemotherapy and no recurrence was observed over the following 6 months.
引用
收藏
页码:62 / 65
页数:4
相关论文
共 50 条
  • [31] Blastic CD56+ natural killer-cell lymphoma with primary cutaneous manifestation
    Berger, TG
    Voll, RE
    Simon, M
    Kiesewetter, F
    ACTA DERMATO-VENEREOLOGICA, 2004, 84 (01) : 53 - 56
  • [32] CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"):: Neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon
    Pilichowska, Monika E.
    Fleming, Mark D.
    Pinkus, Jack L.
    Pinkus, Geraldine S.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 128 (03) : 445 - 453
  • [33] Cutaneous CD4+ CD56+ cell tumors: Report of 6 cases
    Petrella, T
    Dalac, S
    Thomine, E
    Joly, P
    Arnould, L
    Wechsler, J
    Bagot, M
    Bosq, J
    Avril, MF
    Molina, T
    Devitas, A
    Lambert, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (03) : 496 - 496
  • [34] CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate
    Leitenberger, Justin J.
    Berthelot, Cindy N.
    Polder, Kristel D.
    Pro, Barbara
    McLaughlin, Peter
    Jones, Dan
    Duvic, Madeleine
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (03) : 480 - 484
  • [35] Cutaneous CD4+ CD56+ cell tumors: Report of 6 cases.
    Petrella, T
    Dalac, S
    Thomine, E
    Joly, P
    Arnould, L
    Wechsler, J
    Bagot, M
    Bosq, J
    Avril, MF
    Molina, T
    Devidas, A
    Lambert, D
    BLOOD, 1997, 90 (10) : 3936 - 3936
  • [36] Primary CD56+ T/NK cell lymphoma of the colon
    Hyun Soo Kim
    Dong Ki Lee
    Soon Koo Baik
    Sang Ok Kwon
    Mee Yon Cho
    Young Hye Ko
    Journal of Gastroenterology, 2002, 37 : 939 - 946
  • [37] Primary CD56+ T/NK cell lymphoma of the colon
    Kim, HS
    Lee, DK
    Baik, SK
    Kwon, SO
    Cho, MY
    Ko, YH
    JOURNAL OF GASTROENTEROLOGY, 2002, 37 (11) : 939 - 946
  • [38] Cutaneous CD4+ CD56+ hematologic malignancies
    Magro, Cynthia M.
    Porcu, Pierluigi
    Schaefer, Jochen
    Erter, Jack W.
    Furman, Richard R.
    Shitabata, Paul K.
    Crowson, A. Neil
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (02) : 292 - 308
  • [39] A CD56-negative case of blastic natural killer-cell lymphoma (agranular CD4+/CD56+haematodermic neoplasm)
    Petrella, T
    Teitell, MA
    Spiekermann, C
    Meijer, CJLM
    Franck, F
    Enache, I
    BRITISH JOURNAL OF DERMATOLOGY, 2004, 150 (01) : 174 - 176
  • [40] CD4+CD56+Hematodermic Neoplasm Without Cutaneous Involvement
    Sharma, Seema
    Rana, Chanchal
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 : S1 - S3